Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients

Acta Endocrinol (Copenh). 1991 Nov;125(5):502-9. doi: 10.1530/acta.0.1250502.

Abstract

To investigate the relationships between lymphocyte subsets and thyroid function, peripheral blood lymphocytes were analysed with cell surface antigens of activated (HLA-DR+) T, helper T (CD4+ 2H4-, CD4+ 4B4+) and suppressor-inducer T (CD4+ 2H4+, CD4+ 4B4-) cells subsets in 56 patients with Graves' disease, 16 patients with Hashimoto's thyroiditis, 7 patients with typical subacute thyroiditis and 2 patients with the thyrotoxic phase of autoimmune thyroiditis. Both patients with Graves' disease and Hashimoto's thyroiditis had increased percentages of HLA-DR+ T (Ia+ CD3+) cells as well as HLA-DR+ helper-inducer T (Ia+ CD4+) cells, which seemed to be independent of treatments. The percentage of HLA-DR+ suppressor-cytotoxic T (Ia+ CD8+) cells was increased in euthyroid or hypothyroid patients with Graves' disease following treatment, but was normal in hyperthyroid patients. The percentages of Ia+ CD4+ cells and Ia+ CD8+ were also increased in patients with thyroiditis, whereas these abnormal values normalized in the remission phase. These findings suggest that an increase in Ia+ CD4+ cells characteristically occurs during immune system activation in patients with hyperthyroid Graves' disease, Hashimoto's thyroiditis and the thyrotoxic phase of subacute thyroiditis, whereas the activated CD8+ cells in Graves' disease are induced by antithyroidal therapy.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Autoantibodies / analysis
  • CD4 Antigens / analysis
  • CD8 Antigens / analysis
  • Female
  • Flow Cytometry / methods
  • Graves Disease / drug therapy
  • Graves Disease / immunology
  • Graves Disease / pathology
  • HLA-DR Antigens / analysis
  • Humans
  • Immunoglobulins, Thyroid-Stimulating
  • Iodine / therapeutic use
  • Male
  • Methimazole / therapeutic use
  • Middle Aged
  • Propylthiouracil / therapeutic use
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / pathology*
  • Thyroiditis, Autoimmune / drug therapy
  • Thyroiditis, Autoimmune / immunology
  • Thyroiditis, Autoimmune / pathology*
  • Thyroiditis, Subacute / drug therapy
  • Thyroiditis, Subacute / immunology
  • Thyroiditis, Subacute / pathology

Substances

  • Autoantibodies
  • CD4 Antigens
  • CD8 Antigens
  • HLA-DR Antigens
  • Immunoglobulins, Thyroid-Stimulating
  • Methimazole
  • Propylthiouracil
  • Iodine